RetInSight is an AI-powered healthcare startup with the slogan "AI to Eye." The company specializes in leveraging Artificial Intelligence solutions to enhance diagnostic and therapeutic care for individuals at risk of retinal diseases, a leading cause of severe vision loss and blindness. Their innovative approach to retina screening and monitoring involves a first-in-class software that is fully automated, objective, quantitative, and fast. RetInSight's expert-level tools aim to empower ophthalmologists and physicians to deliver precision medicine to their patients, ultimately saving eyesight at the right time, at any place, for everyone. The startup operates in the AI, Health Care, and Information Technology industries, and while details about its founding date and headquarters are not specified, the potential for investment in this emerging area of healthcare technology is significant. With the right investors and support, RetInSight could play a crucial role in transforming the approach to retinal healthcare and addressing a critical medical need.
There is no investment information
No recent news or press coverage available for RetInSight.